Skip to main content
Clinical Trials/NCT00221780
NCT00221780
Unknown
N/A

Importance of Left Ventricular Pacing Site in Biventricular Resynchronization Therapy for Severe Heart Failure

University Hospital, Bordeaux1 site in 1 country33 target enrollmentNovember 2003

Overview

Phase
N/A
Intervention
Not specified
Conditions
Heart Failure
Sponsor
University Hospital, Bordeaux
Enrollment
33
Locations
1
Primary Endpoint
Variation in left ventricular dp/dt max
Last Updated
18 years ago

Overview

Brief Summary

Cardiac resynchronization therapy has been shown to be effective in reducing symptoms and mortality in heart failure patients. However, very few is known about the importance of the left ventricular pacing site. We study in a random order 11 different left ventricular pacing sites and compare their hemodynamics using pressure-volume catheters. The consequences on the surface ECG are also assessed.

Detailed Description

Background. Cardiac resynchronization therapy has been shown to be effective in reducing symptoms and mortality in heart failure patients. However, very few is known about the importance of the left ventricular pacing site. Design. Single-blind, monocentric, randomized cross-over study comparing 11 left ventricular pacing sites in a random order. Intervention. Left ventricular DDD pacing on 11 ventricular sites, prior to the implantation. At each pacing site, a control hemodynamics will be obtained in AAI pacing at the same pacing rate. At each pacing site, 2 AV delays, a short and a long one, will be assessed. Eligibility criteria. Patients referred for cardiac resynchronization therapy for heart failure Outcomes. Hemodynamic measures using pressure-volume catheters.

Registry
clinicaltrials.gov
Start Date
November 2003
End Date
December 2007
Last Updated
18 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Sponsor
University Hospital, Bordeaux

Eligibility Criteria

Inclusion Criteria

  • Heart failure referred for cardiac resynchronization therapy
  • NYHA Class III or IV
  • Informed consent form signed

Exclusion Criteria

  • Hypertension not controlled by treatment
  • Coronary ischemia not controlled by treatment

Outcomes

Primary Outcomes

Variation in left ventricular dp/dt max

Secondary Outcomes

  • pressures and volumes of the left ventricle
  • stroke work
  • surface ECG repolarisation

Study Sites (1)

Loading locations...

Similar Trials